Current neoadjuvant strategies in rectal cancer

Journal of Surgical Oncology

Volumn 101, Issue 4, 2010, Pages 321-326

  Julien, Lucas A ^a   Thorson, Alan G ^a,b,c,d  

^a Department of General Surgery   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c Department of Surgery ^*  (United States)

^d Colon and Rectal Surgery ^*  (United States)

Author keywords

Chemotherapy; Neoadjuvant therapy; Radiation therapy; Rectal cancer; Review

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADD ON THERAPY; ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTINUOUS INFUSION; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; METASTASIS; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; TREATMENT DURATION;

ANTINEOPLASTIC AGENTS; HUMANS; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS;

EID: 77749246603     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21480     Document Type: Review

References (32)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Köckerling F, Reymond MA, Altendorf-Hofmann A, et al.: Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 1998;16:324-329.
3. Nelson H, Petrelli N, Carlin A, et al.: National Cancer Institute Expert Panel. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93:583-596.
4. Frykholm GJ, Glimelius B, Påhlman L: Preoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564-572.
5. Sauer R, Becker H, Hohenberger W, et al.: German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
6. Bosset JF, Collette L, Calais G, et al.: EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114-1123.
7. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336:980-987.
8. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
9. Cammà C, Giunta M, Fiorica F, et al.: Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA 2000;284:1008-1015.
10. Colorectal Cancer Collaborative Group: Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291-1304.
11. Figueredo A, Zuraw L, Wong RK, et al.: Cancer Care Ontario's Program in Evidence-based Care's Gastrointestinal Cancer Disease Site Group. The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: A practice guideline. BMC Med 2003;1:1.
12. Gérard JP, Conroy T, Bonnetain F, et al.: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006;24:4620-4625.
13. Glynne-Jones R, Wallace M, Livingstone JI, et al.: Complete clinical response after preoperative chemoradiation in rectal cancer: Is a "wait and see" policy justified? Dis Colon Rectum 2008;51:10-19.
14. Kim CJ, Yeatman TJ, Coppola D, et al.: Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 2001;234:352-358.
15. García-Aguilar J, Hernandez de Anda E, Sirivongs P, et al.: A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003;46:298-304.
16. Hiotis SP, Weber SM, Cohen AM, et al.: Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: An analysis of 488 patients. J Am Coll Surg 2002;194:131-135.
17. Zmora O, Dasilva GM, Gurland B, et al.: Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy? Dis Colon Rectum 2004;47:1607-1612.
18. Crane CH, Skibber JM, Feig BW, et al.: Response to preoperative chemoradiation increases the use of spincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer 2003;97:517-524.
19. Janjan NA, Abbruzzese J, Pazdur R, et al.: Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol 1999;51:153-160.
20. Brown CL, Ternent CA, Thorson AG, et al.: Response to preoperative chemoradiation in stage II and III rectal cancer. Dis Colon Rectum 2003;46:1189-1193.
21. Giacchetti S, Itzhaki M, Gruia G, et al.: Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999;10:663-669.
22. Lévi F, Zidani R, Brienza S, et al.: A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer Chronotherapy. Cancer 1999;85:2532-2540.
23. Adam R, Avisar E, Ariche A, et al.: Five-year surival following hepatic resection after neoadjuvant therapy for nonresectable colorectal liver metastases. Ann Surg Oncol 2001;8:347-353.
24. Adam R, Pascal G, Castaing D, et al.: Tumor progression while on chemotherapy: A contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052-1061.
25. Ekberg H, Tranberg KG, Andersson R, et al.: Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986;73:727-731.
26. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery 1988;103:278-288.
27. Pedersen IK, Burcharth F, Roikjaer O, et al.: Resection of liver metastases from colorectal cancer: Indication and results. Dis Colon Rectum 1994;37:1078-1082.
28. Verhoef C, van der Pool AE, Nuyttens JJ, et al.: The "liver-first approach" for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 2009;52:23-30.
29. Mentha G, Majno PE, Andres A, et al.: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 2006;93:872-878.
30. Stelzner S, Hellmich G, Koch R, et al.: Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: A multivariate analysis. J Surg Oncol 2005;89:211-217.
31. Moran MR, Rothenberger DA, Lahr CJ, et al.: Palliation for rectal cancer: Resection? Anastomosis? Arch Surg 1987;122:640-643.
32. ClinicalTrials.gov. [Online] U.S. National Institutes of Health. [Cited: August 5, 2009.] http://www.clinicaltrials.gov